• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[干扰素系统。生物学原理与临床应用综述]

[The interferon system. A review of biological principles and clinical uses].

作者信息

Schneider F J

出版信息

Z Gesamte Inn Med. 1986 Nov 15;41(22):613-8.

PMID:2436387
Abstract

Interferons are endogenous proteins produced by vertebrates in response to viral infections and is immunoregulatory agents. Three types of interferon are known today: IFN-alpha, IFN-beta und IFN-gamma which show different degree of relationship to each other in molecular structure and activity. Several interferons are produced in large amount by recombinant DNA technology. Their most important properties are their antiviral activity, their antiproliferative and immunoregulatory activities. Clinical trials showed that interferons can be used as therapeutic agents in viral infections and malignant diseases. Results of treatment in certain viral infections or virally induced tumors and some particular haematologic malignancies are very good. Many frequent forms of tumors still respond less or not at all to interferon treatment. Interferons have many different effects in vivo and can act synergistically with other agents. Further success in cancer therapy can therefore be expected from investigations on optimum dose schedule and effective combination regimes.

摘要

干扰素是脊椎动物在病毒感染时产生的内源性蛋白质,是免疫调节剂。如今已知有三种类型的干扰素:α-干扰素、β-干扰素和γ-干扰素,它们在分子结构和活性上彼此呈现出不同程度的关联。几种干扰素通过重组DNA技术大量生产。它们最重要的特性是抗病毒活性、抗增殖活性和免疫调节活性。临床试验表明,干扰素可作为病毒感染和恶性疾病的治疗药物。在某些病毒感染、病毒诱导的肿瘤以及一些特定的血液系统恶性肿瘤中的治疗效果非常好。许多常见的肿瘤形式对干扰素治疗的反应仍然较小或根本没有反应。干扰素在体内有许多不同的作用,并且可以与其他药物协同发挥作用。因此,通过对最佳剂量方案和有效联合治疗方案的研究,有望在癌症治疗方面取得进一步的成功。

相似文献

1
[The interferon system. A review of biological principles and clinical uses].[干扰素系统。生物学原理与临床应用综述]
Z Gesamte Inn Med. 1986 Nov 15;41(22):613-8.
2
[Interferons--biologic principles and clinical uses].[干扰素——生物学原理与临床应用]
Klin Padiatr. 1985 Jul-Aug;197(4):263-7. doi: 10.1055/s-2008-1033980.
3
[Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].[干扰素:生理学、药理学及药物治疗学视角]
J Pharmacol. 1983;14 Suppl 3:105-16.
4
Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.干扰素联合疗法在体外增强抗丙型肝炎病毒的抗病毒活性。
Antiviral Res. 2005 Jan;65(1):23-34. doi: 10.1016/j.antiviral.2004.09.002.
5
[Current status of interferon therapy].[干扰素治疗的现状]
Wien Med Wochenschr. 1986 Apr 30;136(7-8):163-72.
6
[Interferon--properties and action].[干扰素——特性与作用]
Wiad Lek. 1989;42(19-21):1086-91.
7
[Alpha interferons--new therapeutic modalities].[α干扰素——新的治疗方式]
Med Pregl. 1998 Mar-Apr;51(3-4):135-9.
8
Independent evolution of antiviral and growth-modulating activities of interferon.干扰素抗病毒和生长调节活性的独立进化。
J Biol Response Mod. 1985 Oct;4(5):447-59.
9
[Possibilities and limits of the use of interferons in the clinic].[干扰素在临床应用中的可能性与局限性]
Schweiz Med Wochenschr. 1989 Nov 4;119(44):1539-43.
10
Interferon-induced alterations in cells: relevance to viral and nonviral diseases.干扰素诱导的细胞改变:与病毒和非病毒疾病的相关性。
Lab Invest. 1983 Jul;49(1):4-18.